YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial and development strategy. The ...
Wellbeing Magazine on MSN
The hidden fatigue factor: How your methylation genes hold the key to lasting energy
If you find yourself consistently exhausted despite a healthy lifestyle, it might not be laziness or aging. Instead, the root ...
Prostate cancer causes around 12,000 deaths each year but the available tests are unreliable according to experts ...
Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...
Women who had two to three children in their late 20s and early 30s showed the slowest aging and best survival rates, ...
Scientists at the University of Cambridge are developing a blood test that could transform how prostate cancer is detected in ...
Freenome today announced an initiative to advance its blood-based early cancer screening program by leveraging NVIDIA deep learning technology and expertise to improve the recognition of ...
The world’s first early-detection blood test for pancreatic cancer is set to be launched in Australia, and is predicted to ...
Biological age tests measure how fast your body is aging compared to your actual age. These tests rely on biomarkers tied to ...
YD BioMed expects to advance two lead ophthalmology programs utilizing its LSC Exosome platform, each supported by targeted regulatory and clinical milestones, which the timing of these milestones ...
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback